Articles related to Hematology

This study provides new insights into using electronic health records as an efficient tool for predicting survival outcomes in SCA treatment, highlighting the significant role of hydroxyurea in lowering mortality rates.

Enhance your clinical decision-making skills in the management of ESA-refractory LR-MDS. Register now for actionable insights and the latest research findings.

Learn how CRISPR-Cas9 gene editing holds the promise of elevating fetal hemoglobin levels and significantly reducing sickle cell disease manifestations. Explore the study’s findings to consider this potential game-changer for your practice.

The FDA’s recent decision allows Fulcrum Therapeutics to continue its Phase 1b trial of FTX-6058, an oral therapy for SCD. The trial aims to explore the drug’s potential in increasing fetal hemoglobin levels, offering a new avenue for treatment.

Home-based therapies are emerging as a viable solution to the challenges faced by global healthcare systems, particularly for conditions like sickle cell disease. Dive deeper into the research and implications for patient care.

The use of reticulocyte hemoglobin content (CHr) presents a significant advancement in diagnosing iron-deficiency anemia. CHr’s potential in early detection, differentiation of hematologic conditions, and real-time assessment could pave the way for more precise and timely patient care.